RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $65,500 | -89.4% | 50,000 | +646.2% | 0.06% | -90.0% |
Q4 2023 | $619,418 | +2035.0% | 6,701 | -75.6% | 0.56% | +1646.9% |
Q3 2023 | $29,013 | -23.5% | 27,500 | 0.0% | 0.03% | -23.8% |
Q2 2023 | $37,950 | +21.6% | 27,500 | +5.8% | 0.04% | +82.6% |
Q1 2023 | $31,200 | -3.2% | 26,000 | 0.0% | 0.02% | -4.2% |
Q4 2022 | $32,240 | +79.1% | 26,000 | +4.0% | 0.02% | +84.6% |
Q3 2022 | $18,000 | -43.8% | 25,000 | 0.0% | 0.01% | -43.5% |
Q2 2022 | $32,000 | -57.3% | 25,000 | +6.4% | 0.02% | -52.1% |
Q1 2022 | $75,000 | +31.6% | 23,500 | 0.0% | 0.05% | +33.3% |
Q4 2021 | $57,000 | -31.3% | 23,500 | 0.0% | 0.04% | -37.9% |
Q3 2021 | $83,000 | -20.2% | 23,500 | 0.0% | 0.06% | -18.3% |
Q2 2021 | $104,000 | +30.0% | 23,500 | 0.0% | 0.07% | +20.3% |
Q1 2021 | $80,000 | +2.6% | 23,500 | +9.3% | 0.06% | -9.2% |
Q4 2020 | $78,000 | +62.5% | 21,500 | +7.5% | 0.06% | +38.3% |
Q3 2020 | $48,000 | +71.4% | 20,000 | +29.0% | 0.05% | +62.1% |
Q2 2020 | $28,000 | +40.0% | 15,500 | +17.0% | 0.03% | +20.8% |
Q1 2020 | $20,000 | -23.1% | 13,250 | +8.2% | 0.02% | 0.0% |
Q4 2019 | $26,000 | – | 12,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.02% |